Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 09 March 2023
Sec. Cardio-Oncology
Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1169176

Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story

This article is a correction to:

  1. Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

    1. Read original article
\r\nIrma BiscegliaIrma Bisceglia1Maria Laura CanaleMaria Laura Canale2Giuseppina Gallucci Giuseppina Gallucci3*Fabio Maria TurazzaFabio Maria Turazza4Chiara LestuzziChiara Lestuzzi5Iris ParriniIris Parrini6Giulia RussoGiulia Russo7Nicola MaureaNicola Maurea8Vincenzo QuagliarielloVincenzo Quagliariello8Stefano OlivaStefano Oliva9Stefania Angela Di FuscoStefania Angela Di Fusco10Fabiana LucFabiana Lucà11Luigi TarantiniLuigi Tarantini12Paolo TrambaioloPaolo Trambaiolo13Antonella MoreoAntonella Moreo14Giovanna GeraciGiovanna Geraci15Domenico GabrielliDomenico Gabrielli16Michele Massimo GuliziaMichele Massimo Gulizia17Fabrizio OlivaFabrizio Oliva18Furio Colivicchi\r\nFurio Colivicchi10
  • 1Integrated Cardiology Services, Cardio-Thoracic-Vascular Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
  • 2Cardiology Department, Nuovo Ospedale Versilia Lido di Camaiore Lucca, Camaiore, Italy
  • 3Cardio-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Referral Cancer Center of Basilicata, Rionero in Vulture, Italy
  • 4Cardiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  • 5Azienda Sanitaria Friuli Occidentale (ASFO) Cardiac and Cardio-Oncologic Rehabilitation Service at Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy
  • 6Cardiology Department, Ospedale Mauriziano Umberto I, Turin, Italy
  • 7Cardiovascular and Sports Medicine Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) Trieste, Trieste, Italy
  • 8Cardiology Department, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy
  • 9Cardio-Oncology Department, Istituto Tumori Giovanni Paolo II, Bari, Italy
  • 10Clinical and Rehabilitation Cardiology Department, Ospedale San Filippo Neri, Rome, Italy
  • 11Cardiology Department, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
  • 12Divisione di Cardiologia, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale- IRCCS di Reggio-Emilia, Reggio Emilia, Italy
  • 13Cardiology Department, Sandro Pertini Hospital, Rome, Italy
  • 14A. De Gasperis Cardio Center, Aziende Socio Sanitarie Territoriali (ASST) Grande Ospedale Metropolitano Niguarda, Milan, Italy
  • 15Cardiology Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
  • 16Cardio-Thoracic-Vascular Department, San Camillo-Forlanini Hospital, Rome, Italy
  • 17Cardiology Department, Garibaldi Hospital, Catania, Italy
  • 18Dipartimento Cardiotoracovascolare, Cardiology 1-Cath Lab, Coronary Care Unit (CCU), ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

A Corrigendum on

Cardio-oncology in the COVID Era (Co & Co): The never ending story

By Bisceglia I, Canale ML, Gallucci G, Turazza FM, Lestuzzi C, Parrini I, Russo G, Maurea N, Quagliariello V, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Moreo A, Geraci G, Gabrielli D, Gulizia MM, Oliva F and Colivicchi F (2022) Front. Cardiovasc. Med. 9:821193. doi: 10.3389/fcvm.2022.821193

Incorrect Affiliation

In the published article, there was an error in affiliations [4] and [9]. Affiliation 4 should be “4. Cardiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy”. Instead of “4. Cardiology Department, National Cancer Institute Foundation, Milan, Italy”.

Affiliation 9 should be “9. Cardio-Oncology Department, Istituto Tumori Giovanni Paolo II, Bari, Italy”, Instead of “Cardiology Department, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: SARS-CoV-2, COVID-19, cancer, cardiovascular disease, cardiotoxicity, syndemic, telehealth

Citation: Bisceglia I, Canale ML, Gallucci G, Turazza FM, Lestuzzi C, Parrini I, Russo G, Maurea N, Quagliariello V, Oliva S, Angela Di Fusco S, Lucà F, Tarantini L, Trambaiolo P, Moreo A, Geraci G, Gabrielli D, Gulizia MM, Oliva F and Colivicchi F (2023) Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story. Front. Cardiovasc. Med. 10:1169176. doi: 10.3389/fcvm.2023.1169176

Received: 18 February 2023; Accepted: 22 February 2023;
Published: 9 March 2023.

Approved by: Frontiers in Cardiovascular Medicine, Frontiers Media SA, Switzerland

© 2023 Bisceglia, Canale, Gallucci, Turazza, Lestuzzi, Parrini, Russo, Maurea, Quagliariello, Oliva, Angela Di Fusco, Lucà, Tarantini, Trambaiolo, Moreo, Geraci, Gabrielli, Gulizia, Oliva and Colivicchi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Giuseppina Gallucci cGluYS5nYWxsdWNjaUB0aXNjYWxpLml0

Specialty Section: This article was submitted to Cardio-Oncology, a section of the journal Frontiers in Cardiovascular Medicine

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.